KENNETH BATE - 05 Jun 2024 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate
Issuer symbol
ATXS
Transactions as of
05 Jun 2024
Transactions value $
$0
Form type
4
Filing time
06 Jun 2024, 16:05:11 UTC
Previous filing
03 Apr 2024
Next filing
27 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +14.1K $0.00 14.1K 05 Jun 2024 Common Stock 14.1K $9.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 5, 2024 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.